These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26382315)

  • 1. Bone structure and turnover in postmenopausal women with type 2 diabetes mellitus.
    Razi F; Esmaili M; Esfahani EN; Yaghmaei P; Qorbani M; Mohammadi Z; Keshtkar A; Khashayar P; Larijani B
    Menopause; 2016 Mar; 23(3):280-5. PubMed ID: 26382315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral in pre- and postmenopausal women with insulin-dependent and non-insulin-dependent diabetes mellitus.
    Christensen JO; Svendsen OL
    Osteoporos Int; 1999; 10(4):307-11. PubMed ID: 10692980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma periostin as a biomarker of osteoporosis in postmenopausal women with type 2 diabetes.
    Li J; Niu X; Si Q; Song Q; Jin M; Zhou R; Sun Y; Li J; Wang Q
    J Bone Miner Metab; 2021 Jul; 39(4):631-638. PubMed ID: 33566208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone turnover biomarkers in obese postmenopausal Saudi women with type-II diabetes mellitus.
    Alselami NM; Noureldeen AF; Al-Ghamdi MA; Khan JA; Moselhy SS
    Afr Health Sci; 2015 Mar; 15(1):90-6. PubMed ID: 25834535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women.
    Fodor D; Bondor C; Albu A; Simon SP; Craciun A; Muntean L
    J Investig Med; 2013 Jan; 61(1):15-21. PubMed ID: 23117696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes.
    Anaforoglu I; Nar-Demirer A; Bascil-Tutuncu N; Ertorer ME
    J Diabetes Complications; 2009; 23(1):12-7. PubMed ID: 18413190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship among insulinlike growth factor I concentrations, bone mineral density, and biochemical markers of bone turnover in postmenopausal women: a population-based study.
    Nabipour I; Larijani B; Beigi S; Jafari SM; Amiri M; Assadi M; Pazoki R; Amiri Z; Sanjdideh Z
    Menopause; 2008; 15(5):934-9. PubMed ID: 18451743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship of iron overload to bone mass density and bone turnover in postmenopausal women with fragility fractures of the hip].
    Zhang LL; Jiang XF; Ai HZ; Jin ZD; Xu JX; Wang B; Xu W; Xie ZG; Zhou HB; Dong QR; Xu YJ
    Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):518-21. PubMed ID: 24091266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association between bone turnover markers, bone mineral density and vitamin D in Moroccan postmenopausal women].
    Elmaataoui A; Elmachtani Idrissi S; Dami A; Bouhsain S; Chabraoui L; Ouzzif Z
    Pathol Biol (Paris); 2014 Feb; 62(1):49-54. PubMed ID: 24461391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements.
    Akin O; Göl K; Aktürk M; Erkaya S
    Gynecol Endocrinol; 2003 Feb; 17(1):19-29. PubMed ID: 12724015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus.
    Canecki-Varžić S; Prpić-Križevac I; Bilić-Ćurčić I
    BMC Endocr Disord; 2016 Mar; 16():14. PubMed ID: 26940634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of osteoporosis and vertebral fractures in postmenopausal women with type 2 diabetes mellitus and their relationship with duration of the disease and chronic complications.
    Viégas M; Costa C; Lopes A; Griz L; Medeiro MA; Bandeira F
    J Diabetes Complications; 2011; 25(4):216-21. PubMed ID: 21458300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum adiponectin level in osteoporotic postmenopausal women with type 2 diabetes mellitus.
    Al-Osami MH; Hameed EK
    Diabetes Metab Syndr; 2018 Nov; 12(6):939-942. PubMed ID: 29853264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study.
    Jansen RB; Christensen TM; Bülow J; Rørdam L; Holstein PE; Jørgensen NR; Svendsen OL
    J Diabetes Complications; 2018 Feb; 32(2):164-170. PubMed ID: 29196119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes.
    Yamamoto M; Yamaguchi T; Nawata K; Yamauchi M; Sugimoto T
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1277-84. PubMed ID: 22337915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of osteoporosis in postmenopausal women with type 2 diabetes mellitus: a three-year longitudinal study with phalangeal QUS measurements.
    Neglia C; Agnello N; Argentiero A; Chitano G; Quarta G; Bortone I; Della Rosa G; Caretto A; Distante A; Colao A; Di Somma C; Migliore A; Auriemma RS; Piscitelli P
    J Biol Regul Homeost Agents; 2014; 28(4):733-41. PubMed ID: 25620182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of osteoporosis among Iranian postmenopausal women with type 2 diabetes: A systematic review and meta-analysis.
    Parizad N; Baghi V; Karimi EB; Ghanei Gheshlagh R
    Diabetes Metab Syndr; 2019; 13(4):2607-2612. PubMed ID: 31405683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.